Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
NCT05141305
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
516
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Stroke, Acute
Interventions
DRUG:
tenecteplase (0.25 mg/kg, Max 25 mg)
DRUG:
standard medical treatment
Sponsor
Beijing Tiantan Hospital